RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Estrogen receptor alpha regulates key genomic regions of t-helper 17 and T-regulatory cells in Multiple Sclerosis: a new potential biomarker of disease activity.
2016-01-01 Marinella, Clerico; Santina, Cutrupi; De Mercanti Stefania, ; Simona, Rolla; Andrea, Iannello; Giulio, Ferrero; Bortoli Michele, De; Luca, Durelli
Estrogen Receptor Alpha Regulates Key Genomic Regions of Thelper 17 and T Regulatory Cells in Multiple Sclerosis: A New Potential Biomarker of Disease Activity
2016-01-01 Clerico, M.; Cutrupi, S.; De Mercanti, S.; Rolla, S.; Iannello, A.; Ferrero, G.; De Bortoli, M.; Durelli, L. .
Estrogen receptor alpha role in multiple sclerosis patients: trying to identify a new biomarker of disease activity
2015-01-01 Clerico, M; Cutrupi, S; De Mercanti, S; Virgilio, E; Iannello, A; De Bortoli, M; Durelli, L
Evaluation of high-dose interferon beta-1b in relapsing-remitting ms non-responder patients: the optims trial. safety data.
2003-01-01 E.VERDUN; A. RICCI; M. CLERICO; P. BARBERO; M. IAMPAGLIA; L. DURELLI; AND THE OPTIMS TRIAL STUDY GROUP
Evaluation of mitochondrial manganese in leukocyte of multiple sclerosis patients.
2003-01-01 M.A. CUCCI; A. NONNATO; P. BARBERO; L. BRANCIFORTE; A. RICCI; E. VERDUN; M. CLERICO; A. PIPIERI; A. CAROPRESO; G. PESCARMONA; L. DURELLI
Every-other-day interferon beta-1b compared with once weekly interferon beta 1-a in ms. further analysis of treatment effect on mri activity and neutralizing antibodies (nabs) in the INCOMIN trial
2004-01-01 P. BARBERO; M. BERGUI; A. RICCI; E. VERSINO; A. PIPIERI; E. VERDUN; M. CLERICO; L. GIORDANO; A. CUCCI; L. DURELLI; INCOMIN STUDY GROUP
Friedreich's ataxia patients and caregivers information seeking behaviour
2016-01-01 De Mercanti, S.; Barbero, P.; Iudicello, M.; Artusi, C.A.; Manera, U.; Durelli, L.; Clerico, M. .
High dose interferon beta-1b in aggressive Multiple Sclerosis. tolerability, clinical and mri results after one year of treatment
2006-01-01 A. PIPIERI; P. BARBERO; M. BERGUI; E. VERSINO; M. CLERICO; L. GIORDANO; L. DELFICO; G. CONTESSA; A.M. CUCCI; E. VERDUN; I. PESCI; L. MANNESCHI; E. CARTECHINI; E. PUCCI; G. GIULIANI; E. MONTANARI; L. DURELLI
How to prevent Conversion from Clinically Isolated Syndromes To clinically Defined Multiple Sclerosis? A Cochrane Meta-Analysis of Published Trials
2008-01-01 Marinella Clerico; Fabrizo Faggiano; Jacqueline Palace; Maria Tintore' Subirana; George Rice; Luca Durelli
IFN beta-1b in multiple sclerosis: comparing two different doses (the Optims Study).
2004-01-01 E. VERDUN; P. BARBERO; A. PIPIERI; A. RICCI; M. CLERICO; A. CUCCI; M. BERGUI; E. VERSINO; L. GIORDANO; M. ZAFFARONI; E. MONTANARI; G. GIULIANI; L. DURELLI; AND THE OPTIMS STUDY GROUP
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Estrogen receptor alpha regulates key genomic regions of t-helper 17 and T-regulatory cells in Multiple Sclerosis: a new potential biomarker of disease activity. | 2016 | Marinella, Clerico; Santina, Cutrupi; De Mercanti Stefania, ; Simona, Rolla; Andrea, Iannello; Giulio, Ferrero; Bortoli Michele, De; Luca, Durelli | |
| Estrogen Receptor Alpha Regulates Key Genomic Regions of Thelper 17 and T Regulatory Cells in Multiple Sclerosis: A New Potential Biomarker of Disease Activity | 2016 | Clerico, M.; Cutrupi, S.; De Mercanti, S.; Rolla, S.; Iannello, A.; Ferrero, G.; De Bortoli, M.; Durelli, L. . | |
| Estrogen receptor alpha role in multiple sclerosis patients: trying to identify a new biomarker of disease activity | 2015 | Clerico, M; Cutrupi, S; De Mercanti, S; Virgilio, E; Iannello, A; De Bortoli, M; Durelli, L | |
| Evaluation of high-dose interferon beta-1b in relapsing-remitting ms non-responder patients: the optims trial. safety data. | 2003 | E.VERDUN; A. RICCI; M. CLERICO; P. BARBERO; M. IAMPAGLIA; L. DURELLI; AND THE OPTIMS TRIAL STUDY GROUP | |
| Evaluation of mitochondrial manganese in leukocyte of multiple sclerosis patients. | 2003 | M.A. CUCCI; A. NONNATO; P. BARBERO; L. BRANCIFORTE; A. RICCI; E. VERDUN; M. CLERICO; A. PIPIERI; A. CAROPRESO; G. PESCARMONA; L. DURELLI | |
| Every-other-day interferon beta-1b compared with once weekly interferon beta 1-a in ms. further analysis of treatment effect on mri activity and neutralizing antibodies (nabs) in the INCOMIN trial | 2004 | P. BARBERO; M. BERGUI; A. RICCI; E. VERSINO; A. PIPIERI; E. VERDUN; M. CLERICO; L. GIORDANO; A. CUCCI; L. DURELLI; INCOMIN STUDY GROUP | |
| Friedreich's ataxia patients and caregivers information seeking behaviour | 2016 | De Mercanti, S.; Barbero, P.; Iudicello, M.; Artusi, C.A.; Manera, U.; Durelli, L.; Clerico, M. . | |
| High dose interferon beta-1b in aggressive Multiple Sclerosis. tolerability, clinical and mri results after one year of treatment | 2006 | A. PIPIERI; P. BARBERO; M. BERGUI; E. VERSINO; M. CLERICO; L. GIORDANO; L. DELFICO; G. CONTESSA; A.M. CUCCI; E. VERDUN; I. PESCI; L. MANNESCHI; E. CARTECHINI; E. PUCCI; G. GIULIANI; E. MONTANARI; L. DURELLI | |
| How to prevent Conversion from Clinically Isolated Syndromes To clinically Defined Multiple Sclerosis? A Cochrane Meta-Analysis of Published Trials | 2008 | Marinella Clerico; Fabrizo Faggiano; Jacqueline Palace; Maria Tintore' Subirana; George Rice; Luca Durelli | |
| IFN beta-1b in multiple sclerosis: comparing two different doses (the Optims Study). | 2004 | E. VERDUN; P. BARBERO; A. PIPIERI; A. RICCI; M. CLERICO; A. CUCCI; M. BERGUI; E. VERSINO; L. GIORDANO; M. ZAFFARONI; E. MONTANARI; G. GIULIANI; L. DURELLI; AND THE OPTIMS STUDY GROUP |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 04-CONTRIBUTO IN ATTI DI CONVEGNO 109
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 109
Data di pubblicazione
- 2010 - 2017 24
- 2003 - 2009 85
Editore
- Springer-Verlag 36
- Lippincot Williams and Wilkins 12
- Antonio Federico 7
- SAGE publications 7
- Robert A. Gross 6
- SAGE Pubblications 5
- Lippincott Williams and Wilkins 4
- SAGE Publications 4
- Springer 4
- Springer Verlag-Italia 3
Rivista
- JOURNAL OF NEUROLOGY 2
Keyword
- Active learning 1
- Cooperative learning 1
- Flipped classroom 1
- Global education 1
- Global university 1
- INTERFERONI 1
- SCLEROSI MULTIPLA 1
- Student centered teaching methods 1
- TH17 1
- TH22 1
Lingua
- eng 109
Accesso al fulltext
- no fulltext 107
- open 2